Drug Trial Radar · NCT01575834
Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis
Last checked: Nov 20, 2026Latest source record: Aug 28, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
7,180
Actual
Start
Mar 15, 2012
Primary completion
Dec 14, 2015
Study completion Dec 28, 2016
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Apr 12, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 55 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if treatment with romosozumab is effective in preventing fractures in women with postmenopausal osteoporosis
Conditions
- Postmenopausal Osteoporosis
Interventions
RomosozumabDrug
Administered by subcutaneous injection once a month (QM)
PlaceboDrug
Administered by subcutaneous injection once a month (QM)
DenosumabDrug
Administered by subcutaneous injection once every 6 months (Q6M)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With New Vertebral Fracture Through Month 12Time frame: 12 Months
- Percentage of Participants With New Vertebral Fracture Through Month 24Time frame: 24 months
Locations
218 sites in 24 countries. Site status is shown where the registry gives one.
Research Site
Tucson, Arizona
Research Site
Laguna Hills, California
Research Site
Los Angeles, California
Research Site
Sacramento, California
Research Site
Santa Maria, California
Research Site
Walnut Creek, California
Research Site
Lakewood, Colorado
Research Site
Leesburg, Florida
Research Site
Palm Harbor, Florida
Research Site
Plantation, Florida
Research Site
Tampa, Florida
Research Site
Gainesville, Georgia
Research Site
New Orleans, Louisiana
Research Site
Bethesda, Maryland
Research Site
Boston, Massachusetts
Research Site
Detroit, Michigan
Research Site
Albuquerque, New Mexico
Research Site
Asheville, North Carolina
Research Site
Fargo, North Dakota
Research Site
Cincinnati, Ohio
Research Site
Mayfield, Ohio
Research Site
Duncansville, Pennsylvania
Research Site
Denton, Texas
Research Site
Richmond, Virginia
Research Site
Madison, Wisconsin
Research Site
Buenos Aires, Argentina
Research Site
Buenos Aires, Argentina
Research Site
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Research Site
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Research Site
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Research Site
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Research Site
Mar del Plata, Buenos Aires, Argentina
Research Site
Córdoba, Córdoba Province, Argentina
Research Site
Maroubra, New South Wales, Australia
Research Site
St Leonards, New South Wales, Australia
Research Site
Herston, Queensland, Australia
Research Site
Keswick, South Australia, Australia
Research Site
Footscray, Victoria, Australia
Research Site
Geelong, Victoria, Australia
Research Site
Heidelberg West, Victoria, Australia
Showing 40 of 218 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.